Kai Dallmeier
9Patents
1h-index
13Co-inventors
44Inventor score
Filing activity: Sep 26, 2012 → Nov 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10550123B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10076564B2 | Bacterial artificial chromosomes | Emerging Cross-Sectional Technologies | 0 | Active |
| US12012411B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12070494B2 | Chimeric flavivirus lyssavirus vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US11566025B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11680084B2 | Live-attenuated flaviruses with heterologous antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11279704B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11351240B2 | Chimeric yellow fever ZIKA virus strain | Emerging Cross-Sectional Technologies | 0 | Active |
| US10633378B2 | Viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.